Indivior Pharmaceuticals, Inc.
INDV
Revenue
357.00M
▲43.00M▲13.69%
3 Months ChangeAssets
1.95B
▲185.00M▲10.46%
12 Months ChangeLiabilities
1.95B
▲236.00M▲13.74%
12 Months ChangeFree Cash Flow
70.00M
▲109.00M▲279.49%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001193125-26-073363
2026-01-26
Form 8-K
ID: 0001193125-26-021660
2026-01-08
Form 8-K
ID: 0001193125-26-006993
2025-12-22
Form 8-K
ID: 0001625297-25-000078
2025-12-18
Form 8-K
ID: 0001625297-25-000076
2025-12-15
Form 8-K
ID: 0001625297-25-000072
2025-11-20
Form 8-K
ID: 0001625297-25-000069
2025-11-14
Form 8-K
ID: 0001628280-25-052210
2025-10-30
Form 10-Q
ID: 0001628280-25-047530
2025-10-30
Form 8-K
ID: 0001193125-25-257381